MyAverix Finance
TWO · Healthcare
Enimmune corporation (6564)
Biotechnology
Enimmune corporation (6564) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6564
Enimmune corporation (6564) — FAQ
What is 6564's P/E ratio?
The price-to-earnings (P/E) ratio for Enimmune corporation (6564) is 18.00 (data as of 2026-03-23).
Does Enimmune corporation pay a dividend?
Dividend yield is not available in the current snapshot for Enimmune corporation (6564). Check the MyAverix Finance app for the latest dividend data.
What sector is Enimmune corporation in?
Enimmune corporation (6564) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 6564 listed on?
6564 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.